2622 studies found for:    "Hepatitis"
Show Display Options
Rank Status Study
21 Completed A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-450/r;   Drug: ABT-530;   Drug: Ribavirin (RBV)
22 Active, not recruiting Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C
Conditions: RNA Virus Infections;   Flaviviridae Infections;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Vitamin D;   Drug: Vitamin B 12
23 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Conditions: Chronic Hepatitis C;   Decompensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/ritonavir/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
24 Completed
Has Results
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)
Conditions: Hepatitis D, Chronic;   Hepatitis B, Chronic
Intervention: Biological: Peginterferon alfa-2b (PegIntron, SCH 54031)
25 Completed
Has Results
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
Conditions: Chronic Hepatitis C Infection;   Compensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
26 Recruiting Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions
Conditions: Human Immunodeficiency Virus;   Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: antiretroviral drugs
27 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™ ADULT;   Biological: Engerix TM
28 Unknown  Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D
Intervention: Drug: pegylated IFN alfa-2b plus ribavirin
29 Completed Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin
Conditions: Chronic Hepatitis C;   Hepatitis, Viral, Human
Intervention: Drug: EMZ702
30 Not yet recruiting Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)
Conditions: Hepatitis B;   Hepatitis A
Intervention: Procedure: Blood sampling
31 Terminated Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
Conditions: Chronic Hepatitis;   Hepatitis B
Interventions: Drug: Clevudine;   Drug: Adefovir
32 Unknown  Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B;   Biopsy;   Hemodialysis
Intervention: Procedure: Percutaneous liver biopsy
33 Completed
Has Results
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™
34 Recruiting A Two Part, Open-label Study to Evaluate the Safety and Effectiveness of ABT-450/r/ABT-267 or ABT-450/r/ABT-267 and ABT-333 Given With or Without a Drug Called Ribavirin in People With Both Hepatitis C Virus Genotype 1 or 4 Infection and Human Immunodeficiency Virus, Type 1 Infection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
35 Unknown  Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy
Conditions: Hepatitis C;   Hepatitis B
Intervention: Drug: Pegasys; Copegus.
36 Withdrawn A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C
Conditions: Hepatitis C;   Hepatitis C Virus
Interventions: Drug: Fluvastatin;   Drug: Peginterferon alfa2a;   Drug: ribavirin
37 Completed Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Conditions: Hepatitis C;   Hepatitis
Interventions: Drug: Merimepodib;   Drug: PEG-Interferon-alpha 2a (Pegasys®);   Drug: Ribavirin (Copegus®)
38 Completed Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C
Conditions: Hepatitis;   Hepatitis C
Interventions: Drug: Algeron;   Drug: PegIntron
39 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Negative;   Chronic Hepatitis B e Antigen Positive
Intervention: Drug: Peginterferon and Tenofovir
40 Recruiting Therapeutic Option for Hepatitis B and C: a French Cohort
Conditions: Viral Hepatitis B;   Viral Hepatitis C
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years